Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
17.03
0.00 (0.00%)
Aug 26, 2026, 4:00 PM EDT - Market closed
Theravance Biopharma Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Theravance Biopharma stock has a consensus rating of "Hold" and an average price target of $17.67. The average 1-year stock price forecast is 3.76% higher than the current stock price, while the lowest is $17 (-0.18%) and the highest is $19 (+11.57%).
Price Target: $17.67 (+3.76%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Theravance Biopharma stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 1 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 3 | 3 | 4 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 6 | 6 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Hold Maintains $17 | Hold | Maintains | $17 | -0.18% | Aug 11, 2026 |
| BTIG | BTIG | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Jun 29, 2026 |
| JonesTrading | JonesTrading | Hold Downgrades $19 → $17 | Hold | Downgrades | $19 → $17 | -0.18% | Jun 29, 2026 |
| TD Cowen | TD Cowen | Hold Reiterates $15 | Hold | Reiterates | $15 | -11.92% | May 8, 2026 |
| B. Riley Securities | B. Riley Securities | Hold Maintains $14 → $17 | Hold | Maintains | $14 → $17 | -0.18% | Apr 7, 2026 |
Financial Forecast
Revenue This Year
90.68M
from 107.46M
Decreased by -15.62%
Revenue Next Year
97.40M
from 90.68M
Increased by 7.41%
EPS This Year
0.21
from -0.15
EPS Next Year
1.28
from 0.21
Increased by 507.14%
EPS and Forward PE are based on non-GAAP adjusted numbers.